Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Psoriasis”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Testing effectiveness (Phase 2)WithdrawnNCT00788424
What this trial is testing

Topical Application of AS101 for the Treatment of Psoriasis

Who this might be right for
Mild to Moderate Psoriasis
BioMAS Ltd
Early research (Phase 1)Looking for participantsNCT06376474
What this trial is testing

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Who this might be right for
Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd 24
Testing effectiveness (Phase 2)Study completedNCT01000714
What this trial is testing

Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis

Who this might be right for
Mild to Moderate Psoriasis
Etwal Ltd.
Very early researchStudy completedNCT04410237
What this trial is testing

Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System

Who this might be right for
Psoriasis
University Hospitals Cleveland Medical Center 13
Testing effectiveness (Phase 2)WithdrawnNCT02993328
What this trial is testing

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults

Who this might be right for
Plaque Psoriasis
Santalis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06723171
What this trial is testing

Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Type PsorisisPlaque Psoriasis
Io Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT02695940
What this trial is testing

Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis

Who this might be right for
Inverse Psoriasis
LEO Pharma 69
Early research (Phase 1)Looking for participantsNCT07024602
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Ascletis Pharma (China) Co., Limited 94
Early research (Phase 1)Study completedNCT03337022
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis

Who this might be right for
Psoriasis
Celgene 34
Early research (Phase 1)Study completedNCT02303509
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject

Who this might be right for
Psoriasis
UCB Pharma 57
Testing effectiveness (Phase 2)Study completedNCT00593177
What this trial is testing

A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate Psoriasis

Who this might be right for
Psoriasis Vulgaris
Manhattan Pharmaceuticals 61
Testing effectiveness (Phase 2)Study completedNCT01098721
What this trial is testing

A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks

Who this might be right for
Psoriasis
Welichem Biotech Inc. 61
Early research (Phase 1)Study completedNCT06380153
What this trial is testing

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment

Who this might be right for
Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd 26
Large-scale testing (Phase 3)Study completedNCT01763424
What this trial is testing

Nicotinamide in the Treatment of Psoriasis

Who this might be right for
Psoriasis
Isfahan University of Medical Sciences 66
Testing effectiveness (Phase 2)Study completedNCT03000608
What this trial is testing

A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Santalis Pharmaceuticals, Inc. 69
Testing effectiveness (Phase 2)Study completedNCT00995969
What this trial is testing

CT 327 in the Treatment of Psoriasis Vulgaris

Who this might be right for
Psoriasis
Creabilis SA 58
Early research (Phase 1)Study completedNCT03469336
What this trial is testing

Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 18
Not applicableStudy completedNCT05820698
What this trial is testing

The Mediterranean Diet and Time-Restricted Eating Dietary Interventions for Psoriasis Study

Who this might be right for
Psoriasis Vulgaris
King's College London 22
Early research (Phase 1)Study completedNCT02529956
What this trial is testing

Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With Psoriasis

Who this might be right for
Mild to Moderate Psoriasis
UCB Celltech 39
Testing effectiveness (Phase 2)Study completedNCT02494479
What this trial is testing

Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Cellceutix Corporation 115
Load More Results